Shoichi Ito

Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki et al. · The Lancet Neurology · 2010 · 188 citations

Medicine, Neurology, Pharmacotherapy +6

“Cloud‐like enhancement” is a magnetic resonance imaging abnormality specific to neuromyelitis optica

Shoichi Ito, Masahiro Mori, Takahiro Makino et al. · Annals of Neurology · 2009 · 162 citations

Life Sciences, Neurology, Neuroscience +15

“Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis

Tadahiro Yonezu, Shoichi Ito, Masahiro Mori et al. · Multiple Sclerosis Journal · 2013 · 127 citations

Medicine, Neurology, Radiology +17

Distinct molecular mechanisms of <i>HTRA1</i> mutants in manifesting heterozygotes with CARASIL

Hiroaki Nozaki, Taisuke Kato, Megumi Nihonmatsu et al. · Neurology · 2016 · 115 citations

Life Sciences, Genetics, Molecular Genetics +13

Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks

Akiyuki Uzawa, Masahiro Mori, Setsu Sawai et al. · Clinica Chimica Acta · 2013 · 89 citations

Life Sciences, Neurology, Neuroscience +14